SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bobe, R. Articles by Watson, S. P. Search for Related Content PubMed PubMed Citation Articles by Bobe, R. Articles by Watson, S. P. Related Collections Hemostasis, Thrombosis, and Vascular Biology Signal Transduction Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 February 2001, Vol. 97, No. 3, pp. 678-684 HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Phosphatidylinositol 3-kinase-dependent translocation of phospholipase C2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation Régis Bobe, Jonathan I. Wilde, Petra Maschberger, Kanamarlapudi Venkateswarlu, Peter J. Cullen, Wolfgang Siess, and Steve P. Watson From the Department of Pharmacology, University of Oxford, United Kingdom; Department of Pharmacology and Biochemistry, School of Medical Sciences, University of Bristol, United Kingdom; and Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Klinikum Innenstadt, Universität München, Germany.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Activation of the collagen receptor glycoprotein VI (GPVI) by a collagen-related peptide (CRP) induces stimulation of platelets and megakaryocytes through the phosphatidylinositol (PI) 3-kinase-dependent pathway leading to activation of Bruton tyrosine kinase (Btk) and phospholipase C2 (PLC2). Here, we present evidence that both proteins undergo PI 3-kinase-dependent translocation to the plasma membrane on CRP stimulation that is markedly inhibited by wortmannin and LY294002. Translocation of PLC2 but not Btk is also seen in megakaryocytes from X-linked immunodeficiency mice, which have a mutation that reduces the affinity of the pleckstrin homology (PH) domain of Btk for PI 3,4,5-trisphosphate (PI 3,4,5-P3). Activation of PC12 cells by epidermal growth factor (EGF) results in increased PI 3-kinase activity and high PI 3,4,5-P3 levels that trigger translocation of the green fluorescent protein (GFP)-labeled PH of Btk, but not the GFP-labeled PH and tandem Src homology 2 (SH2) domains of PLC2. In contrast to the results with CRP, the G protein-coupled receptor agonist thrombin stimulates PI 3-kinase-independent translocation of Btk but not PLC2. In conclusion, these results demonstrate that in mouse megakaryocytes, CRP leads to PI 3-kinase-dependent translocation of PLC2 and Btk that are independent of one another, whereas thrombin only induces translocation of Btk through a pathway that is independent of PI 3-kinase activity. (Blood. 2001;97:678-684) © 2001 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Adhesion of platelets to the subendothelium at sites of vascular damage leads to their activation and subsequent recruitment of other platelets to form a hemostatic plug. Subendothelial collagen fibers play a critical role in this process, supporting adhesion and activation. Although platelets express several receptors for collagen, the integrin 21 is thought to have a major role in supporting adhesion, whereas the recently cloned glycoprotein VI (GPVI) has been shown to support activation.1,2 GPVI is associated with the Fc receptor -chain in the membrane and induces activation via a tyrosine kinase-dependent pathway that is similar to that used by immune receptors.3 Cross-linking of GPVI by collagen-related protein (CRP) leads to tyrosine phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) on the Fc receptor -chain via a Src family kinase,4-6 which binds the tyrosine kinase Syk via its tandem Src homology 2 (SH2) domains, causing activation.7 Syk triggers a series of downstream events that culminate in the activation of phospholipase C2 (PLC2)-producing second messengers inositol 1,4,5-trisphosphate and 1,2-diacylglycerol. A number of proteins play critical but undefined roles in this sequence of events, including the adapters LAT and SLP-76,8,9 Bruton tyrosine kinase (Btk) and the p85/110 kd heterodimeric form of phosphatidylinositol (PI) 3-kinase.8,10-12 The role of PI 3-kinase in the regulation of Btk and PLC2 by GPVI has received close attention. The PI 3-kinase inhibitors, wortmannin and LY294002, partially block CRP or collagen activation of Btk and PLC2 in human platelets.13,14 Additionally, the Btk pleckstrin homology (PH) domain, which has a high affinity for PI 3,4,5-trisphosphate (PI 3,4,5-P3), inhibits the Ca++ response to CRP in mouse megakaryocytes, whereas a low PI 3,4,5-P3-affinity mutant form of this domain (R28C) has no significant effect.13 This suggests that PI 3,4,5-P3 is the active lipid that mediates the effect of the PI 3-kinase pathway. A similar conclusion has been made for the regulation of PLC2 by FCRIIA in platelets.10 The PI 3-kinase pathway also has a role at the level of Btk, which has a PH domain that binds selectively to PI 3,4,5-P3. In B cells, Btk activation is downstream of Syk and PI 3-kinase,15 and there is evidence for a role for Btk in PLC2 activation via a B-cell linker protein (BLNK).16,17 In human platelets, GPVI activation also leads to PLC2 phosphorylation through a pathway that is partially dependent on Btk.11 However, the presence of BLNK or a homologue has not been described in platelets and the relative position of Btk in the regulation of PLC2 remains unclear. In this study, we provide evidence for a major role of PI 3-kinase in supporting translocation of PLC2 and Btk in human platelets as well as in murine megakaryocytes in response to CRP and demonstrate that the movement of PLC2 is independent of Btk. In addition, we show that thrombin receptor activation does not induce PLC2 translocation but provokes the translocation of Btk through a pathway that is independent of PI 3-kinase.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Materials CRP (GCP*[GPP*]10GCP*G, P* = hydroxyproline; the peptide is cross-linked through the C-terminal cysteines) was a kind gift of Drs Barnes, Knight, and Farndale (Department of Biochemistry, Cambridge, United Kingdom).18 Bovine thrombin, apyrase, and poly-L-lysine (70 000 g/mol) and prostacyclin were from Sigma (Poole, Dorset, United Kingdom). Rabbit polyclonal anti-PLC2, Q20 was from Santa Cruz Biotechnology (Santa Cruz, CA) and rabbit anti-Btk was a generous gift from Dr M. G. Tomlinson (DNAX Research Institute, Palo Alto, CA). Oregon green-488 conjugate goat antirabbit IgG (H+L), Fura-2, and calcium calibration standards were from Molecular Probes (Eugene, OR). Other reagents were from previously described sources.13 Wortmannin and LY294002 were dissolved in DMSO. All other reagents were made up in saline. The concentration of DMSO in the incubation never exceeded 1:1000 final dilution, and an equivalent volume of DMSO was always present in control samples. Preparation of mouse megakaryocytes Mouse megakaryocytes were obtained as described.6 The 50 µL of megakaryocyte suspension was plated onto poly-L-lysine-coated coverslips and allowed to sediment for 3 minutes. Excess of suspension was removed and replaced by Hank's buffer, containing 143 mM NaCl, 5.6 mM KCl, 0.2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 10 mM glucose, and 0.4% bovine serum albumin (BSA), pH 7.2. Experiments were carried out at room temperature, with an external concentration of Ca++ of 200 µM. Preparation of human platelets Human blood was taken from drug-free volunteers on the day of the experiment by using acidic citrate dextrose (ACD; 120 mM sodium citrate, 110 mM glucose, and 80 mM citric acid) as anticoagulant. Platelet-rich plasma was obtained as previously described.13 Washed platelets were resuspended at a concentration of 5 × 108 cells/mL in Tyrode-HEPES buffer containing EGTA (1 mM) and indomethacin (10 µM). Immunostaining of megakaryocytes and platelets Cells were activated by CRP (4 µg/mL) or thrombin (1 U/mL) for the indicated time before fixation by paraformaldehyde 3.2% (wt/vol) in phosphate-buffered saline (PBS) for 10 minutes. Cells were permeabilized by Triton X-100 (0.02%) in PBS for 10 minutes and nonspecific sites were saturated with BSA (2%; wt/vol) for 30 minutes. Megakaryocytes were immunostained for PLC2 or Btk. Primary antibodies were detected by Oregon green-488 conjugate goat antirabbit IgG. Cells were viewed in an inverted microscope (Axiovert S 100, Carl Zeiss, Herts, United Kingdom) under 40 × or 100 × oil immersion lens and analyzed by deconvolution using Openlab software (Improvision, Warwick, United Kingdom). Measurement of Ca++ in single megakaryocytes Megakaryocytes prepared as described previously were viewed on an inverted microscope and stage III/IV megakaryocytes, identified on the basis of size and morphology, as previously described6 were microinjected with Fura-2 and recombinant protein with an Eppendorf micromanipulator 5170 and microinjector 5242 (Eppendorf, Cambridge, United Kingdom). Fura-2 pentapotassium salt was dissolved in standard intracellular buffer19 and was present in the injection needle at a concentration of 2.5 mM, resulting in an estimated intracellular concentration of 200 µM or less. Single-cell digital imaging was carried out by using Openlab software. Fluorescence video images and calculation of intracellular Ca++ ([Ca++]i) were made as previously described.13 Cloning of pleckstrin homology and tandem Src homology 2 domains of PLC2 Two pairs of primers (sense 5'-ATGAAGAGAGCCCTGGACC-3' and antisense 5'-CATCGCTTCCTGGTGTAAG-3') and (sense 5'-GAATTCCTCGAGATGATTGCTGATGCCAAGCT-3' and antisense 5'-GAATTCGGCGCGCTCCAGGAGCTCGGGGGTCT-3' containing the EcoRI restriction site) were designed to amplify respectively the PH and tandem SH2 domains of PLC2 by polymerase chain reaction (PCR) (30 cycles with each cycle being 1 minute at 94°C, 1 minute at 50°C, and 2 minutes at 72°C). The PH domain of PLC2 was subcloned into the EcoRV site of the vector pMosBlue (Amersham Pharmacia Biotech, Little Chalfont Bucks, United Kingdom) and then digested with the restriction enzyme HindIII and KpnI and subcloned into the corresponding restriction sites of pEGFP-N3 (Clontech, Hampshire, United Kingdom). The PCR product of SH2 tandem of PLC2 was digested with the appropriated restriction enzyme and subcloned into the corresponding restriction sites of pEGFP-C1. The construct was fully sequenced before use. The green fluorescent protein (GFP)-fused PH domain of Btk construct was kindly given by Dr T. Balla (Endocrinology and Reproduction Research Branch, NICHD, Bethesda, MD).20 Cell cultures, transfections, and confocal microscopy Translocation of GFP-labeled PH domains was monitored in PC-12 cells after stimulation with epidermal growth factor (EGF) as described.21 After transfection (18 to 24 hours), cells were serum starved for 2 hours before fluorescence analysis at 37°C in Krebs-Ringer phosphate buffer (136 mM NaCl, 4.7 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 5 mM sodium phosphate) containing 2 mM NaHCO3 and 25 mM HEPES (pH 7.4). Fluorescence imaging was performed with a Leica DMIRBE inverted confocal microscope controlled with TCS-NT4 software (Leica, Bucks Milton Keynes, United Kingdom) as previously described.21 Analysis of data Each experiment was performed on megakaryocytes from a minimum of 3 different mice. Data are presented as representative single cells or as mean ± SE. Results were analyzed by an analysis of variance (ANOVA) test. In each case, P < .05 was taken as the minimum value to indicate statistical significance.     Results Top Abstract Introduction Materials and methods Results Discussion References CRP induces PI 3-kinase-dependent translocation of PLC2 and Btk and PI 3-kinase-independent translocation Syk to the plasma membrane in human platelets The location of Syk, Btk, and PLC2 was analyzed in human platelets before and after CRP stimulation with deconvolution microscopy. The proteins were found to be cytosolic in basal conditions and underwent translocation to the plasma membrane after 150 seconds of stimulation by CRP (Figure 1). To test the role of PI 3-kinase, platelets were pretreated by wortmannin for 5 minutes before stimulation by CRP. The inhibition of PI 3-kinase activity had no effect on the translocation of Syk, but both PLC2 and Btk translocation were found to be reduced, suggesting that the PI 3-kinase pathway is involved downstream of Syk but upstream of PLC2 and Btk. View larger version (96K): [in this window] [in a new window]   Figure 1. CRP induces PI 3-kinase-dependent translocation of PLC2 and Btk or PI 3-kinase-independent translocation of Syk in human platelets. Human platelets, stimulated by CRP (4 µg/mL) for 150 seconds, were fixed and stained for Syk, PLC2, or Btk as described in "Materials and methods" to study the protein localization. Platelets were pretreated with wortmannin (wort) 100 nM for 15 minutes before the stimulation by CRP to investigate the role of PI 3-kinase. Scale bar = 2 µm. CRP induces PI 3-kinase-dependent translocation of PLC2 and Btk to the plasma membrane in mouse megakaryocytes Translocation of PLC2 and Btk after activation of GPVI was analyzed in single murine megakaryocytes with deconvolution microscopy. As shown in Figure 2A, PLC2 and Btk were localized in the cytosol under basal conditions and underwent translocation to the plasma membrane after CRP stimulation (Figure 2A). The redistribution of the 2 proteins was measured by comparing the line intensity plots calculated for a cross section of the cell as shown in Figure 2B for PLC2. The distribution ratio of protein was calculated by dividing the fluorescence intensity at the plasma membrane (Ipm) by the intensity in the cytosol (Icyt). The distribution ratio of PLC2 was less than 1.0 in nonstimulated cells (Figure 2Bi), and this value increased to 2.3 after stimulation by CRP, corresponding to an increase in plasma membrane localization relative to the cytosol (Figure 2Bii). Translocation of PLC2 was detected at 60 seconds and peaked between 120 to 150 seconds before returning to the basal level by 600 seconds (Figure 2C). Translocation of Btk to the membrane occurred before that of PLC2, with significant translocation detected at 30 seconds (Figure 2C). View larger version (43K): [in this window] [in a new window]   Figure 2. CRP induces PI 3-kinase-dependent translocation of PLC2 and Btk to plasma membrane. (A) Micrographs show the localization of PLC2 and Btk in wild-type Balb-c mouse megakaryocytes. The megakaryocytes have been preincubated with wortmannin (wort) (100 nM) or LY294002 (50 µM) for 15 minutes and then activated with CRP (4 µg/mL) for 150 seconds. Cells were fixed and stained for PLC2 and Btk as described in "Materials and methods." Distribution was analyzed by fluorescence microscopy and deconvolution for basal, CRP-activated megakaryocytes; wort-pretreated megakaryocytes; and LY294002 (LY)-pretreated megakaryocytes. Scale bar = 20 µm. (B) Distribution of fluorescence intensity in megakaryocytes along the lines shown in panel A was calculated by densitometry. The distributions in (i) and (ii) correspond to basal- and CRP-stimulated samples, respectively. (C) The time course of protein translocation was measured in megakaryocyte in response to CRP (4 µg/mL). The results are shown as distribution ratio (Ipm/Icyt) over time (described in "Results"). (D) Control and wort- or LY294002-pretreated megakaryocytes were stimulated by CRP for 150 seconds, and cells stained for PLC2 or Btk as described in "Materials and methods." The amount of protein at the membrane was calculated as above. All results are expressed as a mean ± SE, and are from at least 8 megakaryocytes from 3 different experiments. * and ** correspond to results significantly different from basal or after stimulation with CRP for 2.5 minutes, respectively. To investigate the role of the PI 3-kinase activity in the translocation of PLC2 and Btk, megakaryocytes were preincubated with the 2 structurally unrelated PI 3-kinase inhibitors, wortmannin or LY294002, for 15 minutes at concentrations that result in a complete inhibition of formation of PI 3,4,5-P3 in response to CRP in platelets.13 Both inhibitors completely blocked the translocation of Btk in response to CRP and reduced translocation of PLC2 by more than 90% (Figure 2A,D). This demonstrates that PI 3-kinase activity is involved in GPVI signaling by recruiting PLC2 and Btk to the plasma membrane. The PH and tandem SH2 domains of PLC2 do not translocate on elevation of PI 3,4,5-P3 Membrane translocation of a number of PH domain-containing proteins such as Btk, Grp1, or centaurin 1, has been shown to be dependent on PI 3-kinase activity in NIH 3T3 and PC12 cells.19,21,22 To investigate the mechanism of translocation of PLC2, we transiently transfected PC12 cells with chimera proteins of GFP fused to the N-terminus PH domain and tandem SH2 domains of PLC2. The GFP-fused PH domain of Btk was used as a positive control in these studies. Using laser scanning confocal microscopy, we studied the resultant subcellular localization of GFP-PH and GFP-tandem SH2 domains of PLC2 before and during stimulation with EGF, an agonist that induces an increase in plasma membrane PI 3,4,5-P3 within these cells.23 In resting PC12 cells, GFP-PH domains of PLC2 and Btk were localized in the cytosol as well as in the nucleus, whereas the GFP-tandem SH2 domain was found primarily in the nucleus (Figure 3). Stimulation with EGF (100 ng/mL) resulted in an almost complete translocation of cytosolic GFP-PH Btk to the plasma membrane but had no effect on the localization of GFP-PH and GFP-tandem SH2 domains of PLC2 (Figure 3). These results demonstrate that, in contrast to Btk, neither the N-terminal PH or SH2 tandem domains of PLC2 are able to undergo translocation to the membrane on elevation of PI 3,4,5-P3. Similar results were also obtained with the PH domain of PLC1 (not shown). View larger version (58K): [in this window] [in a new window]   Figure 3. The PH and tandem SH2 domains of PLC2 do not translocate on EGF stimulation of PC12 cells. C12 cells were transfected with pEGFP-PH domain of Btk or pEGFP-PH or pEGFP-tandem SH2 domain of PLC2. After 24 hours, cells were starved of serum and imaged by laser-scanning confocal microscopy. Images are of PC12 cells in the absence or 1 minute after stimulation with EGF (100 ng/mL). CRP induces translocation of PLC2 but not Btk to the plasma membrane in X-linked immunodeficiency mouse megakaryocytes The fact that both Btk and PLC2 translocate through PI 3-kinase-dependent pathways, with a greater delay for PLC2 than for Btk, raises the question of their interdependence. To determine whether Btk is involved in the translocation of PLC2, we monitored translocation in megakaryocytes from X-linked immunodeficiency (XID) mice. XID mice express a mutant form of Btk in which arginine 28 within the PH domain is substituted by cysteine, resulting in a marked reduction in affinity for PI 3,4,5-P3.24 This mutation results in the loss of Btk translocation to the plasma membrane of the megakaryocyte after CRP activation (Figure 4), demonstrating the importance of the interaction of PI 3,4,5-P3 with this domain. In contrast, translocation of PLC2 to the membrane in XID megakaryocytes is maintained, taking place over a similar time course and with a similar intensity to that seen in controls (Figure 4 and not shown). It was notable that a low level of PLC2 was present in the plasma membrane in the basal XID megakaryocytes, whereas it was absent in controls (Figure 4). This weak membrane localization is reduced when cells were preincubated with wortmannin (100 nM) over 30 minutes suggesting that it is dependent on PI 3-kinase activity (not shown). Wortmannin also inhibited the translocation of PLC2 to plasma membrane in XID megakaryocytes in response to CRP (not shown). These results demonstrate that PI 3-kinase activity is directly involved in the translocation of PLC2, and that this is not dependent on Btk translocation. View larger version (94K): [in this window] [in a new window]   Figure 4. Localization and translocation of PLC2 and Btk in XID megakaryocytes. XID mouse megakaryocytes were stimulated by CRP (4 µg/mL; 90 seconds) and stained for PLC2 and Btk. Cells were analyzed by fluorescence microscopy and deconvolution as described in Figure 1. Scale bar = 20 µm. Each image is representative of 7 megakaryocytes obtained from a minimum of 3 experiments on different animals. Wortmannin inhibits calcium elevation in response to CRP in control and XID mouse megakaryocytes The elevation of [Ca++]i in response to CRP was investigated using single-cell video imaging. CRP stimulated a rapid increase in [Ca++]i before decaying to a plateau.13 Similar time course and magnitude of response was seen in XID megakaryocytes in response to CRP, with the basal level unchanged in both cell types (not shown). The latter observation suggests that the low level of PLC2 associated with the membrane in XID megakaryocytes is unlikely to be functional. The peak [Ca++]i response to CRP was 208 ± 23 nM (n = 13) and 220 ± 43 nM (n = 9) in control and XID megakaryocytes, respectively (Figure 5). These results demonstrate that translocation of Btk is not important for the initial peak of the Ca++ response to CRP. There was, however, a 20% reduction in the size of the plateau phase of the [Ca++]i response to CRP in XID megakaryocytes,25 which may reflect the involvement of Btk in the maintenance of the sustained Ca++ signal. This is similar to the pathway described in B cells after activation of the B-cell receptor.26 View larger version (18K): [in this window] [in a new window]   Figure 5. CRP elevates Ca++ in XID megakaryocytes. Single megakaryocytes from control and XID mice were microinjected with Fura-2, pretreated or not for 15 minutes with wortmannin (wort) (100 nM), and stimulated by CRP (4 µg/mL). Intracellular Ca++ was determined as described in "Materials and methods." The increase in [Ca++]i in response to CRP is shown as histogram showing the mean ± SE. Results are from 8 to 10 cells from a minimum of 4 different mice. *corresponds to results significantly different from basal. The inhibition of PI 3-kinase activity by wortmannin reduces the peak increase in Ca++ in response to CRP in control megakaryocytes to 60 ± 15 nM (n = 9), a lowering of approximately 70% as reported previously.13 XID megakaryocytes were slightly less sensitive to the PI 3-kinase inhibitor wortmannin, with the [Ca++]i response being reduced by 110 ± 23 nM (n = 5), a lowering of approximately 50% (Figure 5). Thrombin induces Btk translocation in XID megakaryocytes Thrombin was observed to stimulate translocation of Btk to the membrane of mouse megakaryocytes, but to have no significant effect on the distribution of PLC2 (Figure 6A). Btk was not evenly distributed on the membrane in thrombin-stimulated cells suggesting localization to specific regions in the membrane. Translocation of Btk in response to thrombin was maintained in the presence of wortmannin (100 nM) and in XID megakaryocytes when measured after 30 seconds (Figure 6A). This demonstrates that translocation is not dependent on the interaction of the PH domain of Btk with PI 3,4,5-P3. Btk was present at the plasma membrane for a shorter period in the XID megakaryocytes compared with controls, returning to the cytosol within 60 seconds of stimulation (Figure 6B). This suggests that thrombin targets Btk to the membrane through a novel pathway that is independent of PI 3,4,5-P3 but that the interaction between Btk and PI 3,4,5-P3 is required to keep the protein at the membrane. The peak elevation of [Ca++]i in response to thrombin was similar in control and XID megakaryocytes. It was also not altered in the presence of wortmannin (Table 1). These results are consistent with our previous report that the peak response to thrombin is not significantly altered after the microinjection of the PH domain of Btk, at a concentration that has been shown to block the response to CRP.13 View larger version (25K): [in this window] [in a new window]   Figure 6. Thrombin stimulates the translocation of Btk to the membrane. (A) Mouse megakaryocytes were stimulated by thrombin (THR) and analyzed for expression of PLC2 and Btk as described in Figure 2. As labeled for each panel, Btk-stained megakaryocytes are unstimulated, THR-stimulated, wortmannin (wort)-treated, or XID megakaryocytes. Scale bar = 20 µm. Each image is representative of 8 megakaryocytes obtained from a minimum of 3 experiments on different animals. (B) The time course of Btk translocation was measured in control and XID megakaryocytes in response to THR (1 U/mL). The results are shown as distribution ratio (described in "Results" ).                                View this table: [in this window] [in a new window]   Table 1. Intracellular Ca++ increase after thrombin activation     Discussion Top Abstract Introduction Materials and methods Results Discussion References In this study, we show that PI 3-kinase activity is required for membrane targeting of PLC2 and Btk in platelets and megakaryocytes using the structurally distinct inhibitors, wortmannin and LY294002. In contrast, Syk translocation is not affected by wortmannin, indicating that PI 3-kinase activity is involved downstream of Syk. Translocation of PLC2 and Btk are distinct events because translocation of PLC2 in response to CRP is not altered in XID megakaryocytes that express a mutant form of Btk that does not move to the membrane. The inhibition of translocation of PLC2 by wortmannin and LY294002 is likely to account for the ability of these PI 3-kinase inhibitors to reduce the peak Ca++ response to CRP in megakaryocytes by approximately 70%, despite the absence of effect on the phosphorylation of PLC2.13 In contrast, the peak Ca++ response to CRP is unaltered in XID megakaryocytes, although there is a slight inhibition (20%) of the plateau phase suggesting a role of Btk in mediating sustained Ca++ entry.25 A more significant role for Btk in the sustained phase of the [Ca++]i response has been proposed in human B cells and platelets on stimulation by the B-cell receptor and GPVI, respectively, based on studies on X-linked agammaglobulinemia (XLA) patients deficient in the kinase.11,27 It seems that Btk plays a greater role in the regulation of PLC2 in humans than in the mouse, in line with the increased severity of the immunodeficiency in humans. It is possible that other Tec family kinase proteins could be involved in this activation pathway14 and compensate for the lack of Btk to different degrees in mouse and human systems. Phosphorylation of Btk in response to CRP is reduced in the presence of wortmannin and LY294002. This is consistent with the proposal that phosphorylation of Btk is mediated by a Src family kinase after translocation to the plasma membrane.28 Studies were performed to identify the domain within PLC2, which supports PI 3-kinase-dependent translocation to the membrane. The GFP-labeled PH domain of PLC2 did not undergo translocation in PC12 cells after elevation of PI 3,4,5-P3. In contrast, the GFP-fused PH domain of Btk underwent translocation to the membrane in PC12 cells confirming previous reports.21 Similarly, the N-terminal PH domain of PLC1 is able to translocate to the membrane on PI 3-kinase activation.19 Bae et al29 have proposed that the tandem SH2 domain supports the interaction of PLC1 with PI 3,4,5-P3. However, there was no detectable translocation to the membrane of the GFP-labeled tandem SH2 domains of PLC2 on elevation of PI 3,4,5-P3 in PC12 cells. It is possible that the lack of translocation is due to the expressed domain being primarily compartmentalized in the nucleus. Translocation of PLC2 may therefore be mediated via another domain in the phospholipase such as the split PH domain, which flanks the tandem SH2 and SH3 domains or via an intermediate protein that has a PI 3,4,5-P3-binding domain. Alternatively, the interaction between the PH and/or tandem SH2 domains may not be strong enough to support translocation to the membrane, but may be sufficient to hold PLC2 at the membrane in the presence of other supporting interactions. For example, the adapter protein LAT, which is anchored in the plasma membrane, has been shown to associate with PLC2 probably via its C-terminal SH2 domain30 and to play a critical role in the regulation of the phospholipase.9 The observations that PI 3-kinase inhibitors block translocation of PLC2 to the membrane, but inhibit the elevation of Ca++ by 70%, have minimal effect on tyrosine phosphorylation of the phospholipase,13 and have important implications for the regulation of the phospholipase. On the face of it, these results could indicate that phosphorylation of PLC2 takes place in the cytosol and that it is unlikely to play a role in the PI-3 kinase-independent increase in Ca++. This does not take into account, however, the presence of other domains within PLC2 that are able to target it to the plasma membrane such as the C-terminal SH2 domain of PLC2, which has been shown to bind to the membrane-localized adapter LAT.30 It is possible that the role of PI 3-kinase is to stabilize PLC2 at the membrane in combination with other interactions. In the presence of PI 3-kinase inhibitors, the association of PLC2 with the membrane would be transient, falling below the level of detection, although it may be long enough for phosphorylation to take place. A model illustrating this is shown in Figure 7. View larger version (13K): [in this window] [in a new window]   Figure 7. Two-step translocation of PLC2. Under basal conditions (A), PLC2 is cytosolic and not phosphorylated, the transmembrane adapter protein LAT is not phosphorylated, and the level of PI 3,4,5-P3 is minimal. After activation of GPVI (B), LAT becomes phosphorylated on tyrosine and associates with the C-terminal domain of PLC2. In addition, GPVI stimulates PI 3-kinase, leading to the formation of PI 3,4,5-P3 in the membrane. The localization of PLC2 in the membrane is stabilized by binding of PI 3,4,5-P3 to the PH domain of PLC2 (C). Interestingly, in this context, there was a residual level of PLC2 on the plasma membrane in basal XID megakaryocytes that could be removed by wortmannin. This suggests that, in the absence of an intact Btk PH domain, a low basal level of PI 3,4,5-P3 may be sufficient to support limited translocation of PLC2 to the membrane. This residual membrane PLC2 is not correlated to an increase of basal [Ca++]i, suggesting that this alone is not sufficient to induce PLC2 activation. It is likely that PLC2 must be targeted to a specific region of the membrane and requires other proteins for activation. The protease thrombin signals through G protein-coupled receptors leading to activation of PLC2. In contrast, thrombin stimulates minimal tyrosine phosphorylation of PLC2 suggesting that this does not play a functional role. Thrombin has been reported to stimulate tyrosine phosphorylation of Btk in human platelets through direct and indirect actions, the latter being mediated through IIb3.11,31 In this study, we show that thrombin also stimulates translocation of Btk but not PLC2 to the membrane of mouse megakaryocytes through a pathway that is insensitive to wortmannin and LY294002 and that is maintained in XID mice. Translocation of Btk by thrombin could be mediated through a direct interaction with G protein  or subunits,32-34 rather than via PI 3-kinase as seen in response to CRP. The translocation response to thrombin in megakaryocytes is independent of IIb3, as there was no added fibrinogen or von Willebrand factor, and neither adhesion molecule is released from stimulated cells. The PH domain of Btk is required to anchor Btk at the membrane at increased stimulation times by thrombin as membrane association is lost after 1 minute in XID cells but not in control cells. Previously, we have reported that Btk has no significant role in human platelet aggregation or peak Ca++ elevation in response to thrombin, as neither response is altered in XLA patients or in the presence of wortmannin.11,13 However, the observation that translocation is not greatly altered in response to thrombin in XID megakaryocytes suggests a need for caution in regard to this conclusion. To conclude, CRP stimulates, via GPVI, PI 3-kinase-dependent translocation of PLC2 and Btk through independent pathways. In contrast, thrombin induces translocation of Btk through a PI 3,4,5-P3-independent pathway. These different pathways of Btk translocation may give rise to synergistic interactions between G protein-coupled and tyrosine kinase-linked receptor agonists.     Footnotes Submitted August 2, 2000; accepted October 5, 2000. Supported by the British Heart Foundation (BHF) and the Wellcome Trust. S.P.W. is a BHF Senior Research Fellow. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Régis Bobe, Department of Pharmacology, University of Oxford, Mansfield Rd, OX1 3QT Oxford, United Kingdom; e-mail: regis.bobe{at}pharm.ox.ac.uk.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Clemetson JM, Polgar J, Magnenat E, Wells TNC, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcR and the natural killer receptors. J Biol Chem. 1999;274:29019-29024[Abstract/Free Full Text]. 2. Watson SP. Collagen receptor signalling in platelets and megakaryocytes. Thromb Haemost. 1999;82:365-376[Medline] [Order article via Infotrieve]. 3. Watson SP, Gibbins J. Collagen receptor signalling in platelets: extending the role of the ITAM. Immunol Today. 1998;19:260-265[CrossRef][Medline] [Order article via Infotrieve]. 4. Briddon SJ, Watson SP. Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets. Biochem J. 1999;338:203-209. 5. Ezumi Y, Shindoh K, Tsuji M, Takayama H. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor  chain complex on human platelets. J Exp Med. 1998;188:267-276[Abstract/Free Full Text]. 6. Melford SK, Turner M, Briddon SJ, Tybulewicz VLJ, Watson SP. Syk and Fyn are required by mouse megakaryocytes for the rise in intracellular calcium induced by a collagen-related peptide. J Biol Chem. 1997;272:27539-27542[Abstract/Free Full Text]. 7. Poole A, Gibbins JM, Turner M, et al. The Fc receptor -chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341[CrossRef][Medline] [Order article via Infotrieve]. 8. Gross B, Lee JR, Clements JL, et al. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor GPVI in platelets. J Biol Chem. 1999;274:5963-5971[Abstract/Free Full Text]. 9. Pasquet JM, Gross B, Quek L, et al. LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol. 1999;19:8326-8334[Abstract/Free Full Text]. 10. Gratacap M-P, Payrastre B, Viala C, Mauco G, Plantavid M, Chap H. Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-2 is an early key event in FcRIIA-mediated activation of human platelets. J Biol Chem. 1998;273:24314-24321[Abstract/Free Full Text]. 11. Quek LS, Bolen J, Watson SP. Regulation of Bruton's tyrosine kinase and phospholipase C2 in collagen-stimulated platelets. Curr Biol. 1998;8:1137-1140[CrossRef][Medline] [Order article via Infotrieve]. 12. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-2. J Exp Med. 1996;184:31-40[Abstract/Free Full Text]. 13. Pasquet JM, Bobe R, Gross B, et al. A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets. Biochem J. 1999;342:171-177. 14. Oda A, Ikeda Y, Ochs HD, et al. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking. Blood. 2000;95:1663-1670[Abstract/Free Full Text]. 15. Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON. Phosphatidylinositol 3-kinase- activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci U S A. 1997;94:13820-13825[Abstract/Free Full Text]. 16. Hashimoto A, Kurosaki M, Gotoh N, Shibuya M, Kurosaki T. Shc regulates epidemal growth factor-induced activation of the JNK signaling pathway. J Biol Chem. 1999;274:20139-20143[Abstract/Free Full Text]. 17. Ishiai M, Kurosaki M, Pappu R, et al. BLNK required for coupling Syk to PLC2 and Rac1-JNK in B cells. Immunity. 1999;10:117-125[CrossRef][Medline] [Order article via Infotrieve]. 18. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J. 1995;306:337-344. 19. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J. Activation of phospholipase C by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 1998;17:414-422[CrossRef][Medline] [Order article via Infotrieve]. 20. Varnai P, Rother KI, Balla T. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J Biol Chem. 1999;274:10983-10989[Abstract/Free Full Text]. 21. Venkateswarlu K, Gunn-Moore F, Tavare JM, Cullen PJ. EGF- and NGF-stimulated translocation of cytohesin-1 to the plasma membrane of PC12 cells requires PI 3-kinase activation and a functional cytohesin-1 PH domain. J Cell Sci. 1999;112:1957-1965[Abstract]. 22. Venkateswarlu K, Oatey PB, Tavare JM, Jackson TR, Cullen PJ. Identification of centaurin-alpha1 as a potential in vivo phosphatidylinositol 3,4,5-trisphosphate-binding protein that is functionally homologous to the yeast ADP-ribosylation factor (ARF) GTPase-activating protein, Gcs1. Biochem J. 1999;340:359-363. 23. Carter AN, Downes CP. Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells [published erratum appears in J Biol Chem. 1992;267:23434]. J Biol Chem. 1992;267:14563-14567[Abstract/Free Full Text]. 24. Rameh LE, Arvidsson A-K, Carraway KL, et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 1997;272:22059-22066[Abstract/Free Full Text]. 25. Pasquet JM, Quek L, Stevens C, et al. Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via Btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J. 2000;19:2793-2802[CrossRef][Medline] [Order article via Infotrieve]. 26. Rawlings DJ. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin Immunol. 1999;91:243-253[CrossRef][Medline] [Order article via Infotrieve]. 27. Scharenberg AM, El-Hillal O, Fruman DA, et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-2,3,4-P3)/Tec kinase dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 1998;17:1961-1972[CrossRef][Medline] [Order article via Infotrieve]. 28. Afar D, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON. Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol. 1996;16:3465-3471[Abstract]. 29. Bae YS, Cantley LG, Chen C-S, Kim S-R, Kwon K-S, Rhee SG. Activation of phospholipase C-g by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998;273:4465-4469[Abstract/Free Full Text]. 30. Gross BS, Melford SK, Watson SP. Evidence that phospholipase C-2 interacts with SLP-76, Syk, LAT, Lyn and the FcR -chain after stimulation of the collagen receptor glycoprotein VI in human platelets. Eur J Biochem. 1999;263:612-623[Medline] [Order article via Infotrieve]. 31. Laffargue M, Ragab-Thomas J, Ragab A, et al. Phosphoionositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets. FEBS Lett. 1998;443:66-70. 32. Langhans-Rajasekaran SA, Wan Y, Huang X-Y. Association of Tsk and Btk tyrosine kinases by G protein subunits. Proc Natl Acad Sci U S A. 1995;92:8601-8605[Abstract/Free Full Text]. 33. Abrams CS, Zhao W, Brass LF. A site of interaction between pleckstrin's PH domains and G beta gamma. Biochim Biophys Acta. 1996;1314:233-238[Medline] [Order article via Infotrieve]. 34. Jiang Y, Ma W, Wan Y, Kozasa T, Hattori S, Huang XY. The G protein alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature. 1998;395:808-813[CrossRef][Medline] [Order article via Infotrieve]. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: A. Ragab, S. Severin, M.-P. Gratacap, E. Aguado, M. Malissen, M. Jandrot-Perrus, B. Malissen, J. Ragab-Thomas, and B. Payrastre Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC{gamma}2 activation Blood, October 1, 2007; 110(7): 2466 - 2474. [Abstract] [Full Text] [PDF] R. Berro, C. de la Fuente, Z. Klase, K. Kehn, L. Parvin, A. Pumfery, E. Agbottah, A. Vertes, S. Nekhai, and F. Kashanchi Identifying the Membrane Proteome of HIV-1 Latently Infected Cells J. Biol. Chem., March 16, 2007; 282(11): 8207 - 8218. [Abstract] [Full Text] [PDF] R. N. Carter, G. Tolhurst, G. Walmsley, M. Vizuete-Forster, N. Miller, and M. P. Mahaut-Smith Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte J. Physiol., October 1, 2006; 576(1): 151 - 162. [Abstract] [Full Text] [PDF] L. Lian, Y. Wang, J. Draznin, D. Eslin, J. S. Bennett, M. Poncz, D. Wu, and C. S. Abrams The relative role of PLC{beta} and PI3K{gamma} in platelet activation Blood, July 1, 2005; 106(1): 110 - 117. [Abstract] [Full Text] [PDF] M. J. Coffey, G. E. Jarvis, J. M. Gibbins, B. Coles, N. E. Barrett, O. R.E. Wylie, and V. B. O'Donnell Platelet 12-Lipoxygenase Activation via Glycoprotein VI: Involvement of Multiple Signaling Pathways in Agonist Control of H(P)ETE Synthesis Circ. Res., June 25, 2004; 94(12): 1598 - 1605. [Abstract] [Full Text] [PDF] N. Watanabe, H. Nakajima, H. Suzuki, A. Oda, Y. Matsubara, M. Moroi, Y. Terauchi, T. Kadowaki, H. Suzuki, S. Koyasu, et al. Functional phenotype of phosphoinositide 3-kinase p85{alpha}-null platelets characterized by an impaired response to GP VI stimulation Blood, July 15, 2003; 102(2): 541 - 548. [Abstract] [Full Text] [PDF] Y. Wu, N. Asazuma, K. Satoh, Y. Yatomi, T. Takafuta, M. C. Berndt, and Y. Ozaki Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase Blood, May 1, 2003; 101(9): 3469 - 3476. [Abstract] [Full Text] [PDF] A. Saxena, P. Morozov, D. Frank, R. Musalo, M. A. Lemmon, E. Y. Skolnik, and B. Tycko Phosphoinositide Binding by the Pleckstrin Homology Domains of Ipl and Tih1 J. Biol. Chem., December 13, 2002; 277(51): 49935 - 49944. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bobe, R. Articles by Watson, S. P. Search for Related Content PubMed PubMed Citation Articles by Bobe, R. Articles by Watson, S. P. Related Collections Hemostasis, Thrombosis, and Vascular Biology Signal Transduction Social Bookmarking                   What's this?

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020